S
ilica nanoparticles have been applied to bioimaging, drug delivery, and therapeutic sensitization owing to their ease of synthesis, high surface area, wellestablished surface modification chemistry and high in vivo stability.
1À7 Silica microshells and nanoshells have been studied for applications in ultrasound imaging, both as contrast agents and sensitizing agents in high intensity focused ultrasound. 8À13 Martinez et al. showed that perfluoropentane filled hollow silica and silicaÀboron microshells could be used as an effective color Doppler ultrasound contrast agent in tissue samples. 9 Ta et al. demonstrated that systemically administered silica nanoshells and microshells could be potentially used to outline well vascularized late stage ovarian tumors in vivo using contrast pulse sequencing contrast ultrasound imaging. 10 Hu et al.
showed that even without a perfluorocarbon agent, it is possible to achieve substantial enhancement of ultrasound contrast using silica microshells when injected within the testicle of a rat. 12 Lin et al. have also demonstrated that tetraethoxysilane (TEOS) derived hollow silica shell particles can be used as ultrasound contrast agents in vitro with contrast pulse sequencing imaging, and that the acoustic properties of the particles depend on shell thickness and material properties. 13 One potential application of silica nanoparticles is in improving current surgical techniques used to mark tumors for removal in breast conservation therapy. Many breast tumors are nonpalpable during surgery; consequently, the current standard for intraoperative identification during breast conservation therapy is to resect around a preoperatively implanted guidewire. 14 However, wire guidance is often problematic resulting in a need for second surgeries. This is due to incomplete resection because the wire often moves during surgery and does not localize tumor margins effectively in three dimensions.
Furthermore, guide wire insertion is painful and must be done the day of surgery while the patient is conscious, thereby creating logistical expense for care providers and causing stress to the patient. An alternative method of intraoperative guidance is the use of radioactive seed localization. Radioactive seeds are injected preoperatively using imaging guidance. Subsequently, the surgeon uses a gamma counter as a guide to extract the tumor. Gray et al. have demonstrated that the use of radioactive seed localization can decrease the rate of reoperation because of positive margins by up to 62%. 16 Similarly,
Hughes et al. found that the negative margin rate increased up to 73% from 54% when comparing radioactive seed localization to wire localization. 17 Unfortunately, radioactive seed localization is less commonly employed due to the radiation exposure to the patient and the personnel. The shielded radioactive seed requires a painful incision for insertion through a tube or large hollow needle. Ultrasound imaging is being explored as a means to improve breast tumor resection. Ultrasound is a low cost real time imaging tool that is commonly used in operating rooms. 15 ,18À21 Rahusen et al. found that in lumpectomies when ultrasound guidance was used, 89% of patients had a negative margin compared with 55% of patients when wire localization was used. 15 However, only a subpopulation of tumors can be visualized with standard ultrasound imaging based on the tumor morphology and specific type of cancer. Some cancers can only be visualized by MRI or by the presence of microcalcifications observed during mammography. 20 These tumors tend to have positive margins more often because they are more likely to have invasive components. 22 Perfluoropentane vapor filled hollow 500 nm ironsilica nanoshells have been developed as an alternative means of marking tumors for standard ultrasound guided surgery. It is proposed that the nanoshells would be injected preoperatively into the tumors using the same image-guidance technique that is employed with guide-wires or radioactive seeds. Injection would use a fine syringe needle to reduce patient discomfort; afterward, color Doppler ultrasound imaging during surgery would guide the surgeon to and around the tumor for complete resection. The ironÀsilica nanoshells are stationary markers that can be used to mark multiple foci for resection, pose no risk to the personnel, and can be injected several days before surgery, thereby overcoming critical deficiencies of guide wires and radioactive seeds. The nanoshells can be employed for all patients, and even those whose tumors cannot be imaged by standard ultrasound imaging.
In studying the biodistribution of silica nanoparticles, He et al. reported that IV administered 45 nm surface modified silica nanoparticles could be excreted through renal clearance in mice as shown by transmission electron microscopy (TEM) and energy dispersive spectroscopy (EDS) of mouse urine. 23 Lu et al. reported the in vivo tolerance, biodistribution, and drug delivery capability of ∼100 nm mesoporous silica nanoparticles; 7 they reported that IV dosing of 50 mg/kg caused very little to no overt reaction and at least 90% of such a dose could be excreted in the urine and feces over 96 h. Furthermore, ICPÀMS biodistribution experiments showed that the highest concentrations of these 100 nm mesoporous silica nanoparticles at 48 h were in the lungs and the implanted tumors. Conversely, Lui et al. observed in mice with 100 nm mesoporous hollow silica nanoparticles that after an IV dose of 80 mg/kg, 85% of the injected dose accumulated primarily in the spleen and the liver after 24 h. This dropped to 60% over the course of 1 week. 24 Detectable traces of the particles could be found even 1 month after injection in the liver, spleen, kidneys, and brain by ICP-OES. Wang et al. used perfluorohexane liquid filled ∼300 nm mesoporous hollow silica nanoshells and found that after an IV dose of 12 mg/rabbit the number of nanoshells detected in the tumor tripled over 24 h (10À33 ng/mg of Si), while after 24 h spleen, liver, and lungs all retained between 35 and 50 ng/mg of Si. Small amounts of nanoshells could be detected in the kidneys throughout the 24 h study (less than 10 ng/mg). 11 Decuzzi et al. measured the biodistribution by ICPÀAES of spherical silica particles ranging from 700 nm to 3000 nm in size; it was reported that for IV injections, as particle size increased, the percentage of the injected dose of particles accumulating in non-RES organs decreased. 25 Of the total injection, ∼1% of 700 nm particles were detected in the kidneys at a high dose of particles, as well as approximately 4% of 1000 nm particles were detected at a low dose indicating that the biodistribution of particles can have dose dependent variability. These previous studies show that the silica nanoparticle/ nanoshell biodistribution is sensitive to their size, composition, processing, payload, and injection site. 
RESULTS AND DISCUSSION
The present study explores the use of surface anchored DTPA for chelating 111 In 3þ to define the biodistribution of silica and biodegradable silica nanoshells. It has been shown that for gas filled silica microshells and nanoshells, that larger particles generate greater ultrasound contrast with imaging modalities such as contrast pulse sequencing. 8 Larger particles are also desirable for application as stationary ultrasound contrast markers to reduce escape from the site of implantation. Biodegradable 100 and 200 nm FeÀSiO 2 nanoshells have been synthesized, but the synthetic method was limited to these smaller sizes. 30, 31 To increase the particle diameter to 500 nm for use as stationary markers in tissue, the quantity of TMOS per given mass of polystyrene templates was reduced in order to account for the reduction in relative surface area of templates due to the increase in diameter. Additionally, the reaction time was extended in order to allow for the mechanically less stable iron-silica coating to grow a thicker wall, so it would not fracture during subsequent calcination. The resulting 500 nm FeÀSiO 2 nanoshells differ from 500 nm pure SiO 2 nanoshells in several ways by TEM ( Figure 1A ,B), the FeÀSiO 2 nanoshells have much thicker walls, more ARTICLE dark regions and increased surface colloidal matter. Nevertheless, the FeÀSiO 2 nanoshells appear to be uniform in bulk as seen by scanning electron microscopy (SEM) ( Figure 1C ). The nanoparticle size distribution seen in Figure 1D was determined from SEM image analysis; the average size and standard deviation of FeÀSiO 2 nanoshells was found to be 512 ( 9 nm, the average size and standard deviation for pure SiO 2 nanoshells was found to be 458 ( 11 nm. The iron content of the FeÀSiO 2 nanoshells, as determined by energy dispersive X-ray spectroscopy, was found to be 4.9 ( 1.5 mol %. 111-Indium is a useful short-lived gamma emitter for biodistribution studies.
26À28 DTPA has proven to be a useful ligand for complexing In(III) in biodistribution studies of gel particles, 26 and the approach is readily adapted for labeling silica based nanoparticles. 3, 5, 29 For example, silica and ironÀsilica nanoshells were functionalized with 3-aminopropyl triethoxysilane (3-APTES) in order to cover the surface of the nanoshell with amine groups for conjugation. 32 Excess 3-APTES was removed and the nanoshells were treated with DTPAÀSCN (or FITC) as shown in Scheme 1. It is well-known that such isothiocyanates will react with primary amines to surface anchor DTPA or fluorescein. 33, 34 The nanoshells functionalized with DTPA, were then radiolabeled by incubation with aqueous 111 InCl 3 . It was observed by dose calibrator that nanoshells which were not functionalized with DTPA did not retain any radioactivity after centrifugation and washing.
For application in breast conservation surgery, the goal envisioned is to preoperatively inject these particles by image guidance in the same fashion that radioactive seeds or guide wires are implanted to help localize tumors precisely for resection. Therefore, it is critical that the particles remain stationary before and throughout surgery. As shown in the ultrasound color Doppler image in Figure 2A , particles injected next to a tumor margin in mastectomy tissue are not transported away from site of localization (also confirmed by cross-sectional fluorescence microscopy). This property allows multiple injections around the tumor to thoroughly outline the margin. Figure 2B is a fluorescence microscopy image of a cross-sectional cut through the injection site. The fluorescence was from fluoroscein isothiocyanate (FITC) that was covalently linked to the surface of the particle; the fluorescence was restricted to an area of several square millimeters, which was consistent with the volume that was injected initially. This confirms the ultrasound imaging result that the particles are retained at the injection site with minimal diffusion.
To validate the application of these nanoshells as a local ultrasound guide marker for tumor resection in vivo, Fe-doped nanoshells were injected intratumorally into eight Py8119 tumor bearing nu/nu mice. The particles were imaged intermittently by color Doppler ultrasound over the course of 10 days ( Figure 3AÀF ). The color Doppler signal width was measured and plotted against time ( Figure 3G ). It was found that ARTICLE the signal persisted for 10 days and decayed linearly with imaging over time. It has been shown that perfluorocarbon gas filled nanoshells have mechanical subpopulations that can be imaged at various ultrasound mechanical index outputs. 8 To maximize the number of simultaneous nanoshells being imaged, a higher mechanical index (1.9) (ultrasound power) was applied. As a result of using a higher mechanical index, a substantial degree of shadowing was observed from the high reflectivity of the particles. This shadowing was observed under ultrasound as an exaggerated color Doppler tail, which embellishes the color Doppler signal along the Y-axis ( Figure 3D ). This shadowing is a well-understood behavior of ultrasound imaging.
To overcome interference from the observed shadowing, the signal width was used to measure the signal decay over time instead of the signal area. As can be seen from Figure 3 AÀF, the nanoshells were well retained by the Py8119 tumor and could be successfully imaged over the course of 10 days. Moreover, as seen in Figure 3G , the signal width was found to decay linearly over time. It is hypothesized that the relatively large size and rigidity of these particles dramatically reduces their diffusion through relatively dense tissue and the extracellular matrix. 35 To determine biodistributions, FeÀSiO 2 and SiO 2 nanoshells were functionalized with DTPA and were radiolabeled with 111 In. Nanoshells were injected intratumorally into a single tumor per mouse (each mouse carried two tumors) and planar γ-scintigraphic imaging was performed as shown in Figure 4AÀH . After 72 h, animals were sacrificed, the organs were harvested, and radioactivity was measured with the γ-counter. As can be seen from the scintigraphic images in Figure 4AÀH , particles appear to be well retained at the injection site in the tumor. Note the particles cover a larger volume for the SiO 2 nanoshells since that particular tumor was slightly larger than the tumor used for the FeÀSiO 2 nanoshells. Analysis of individual organs by γ-counting ( Figure 4I ) showed the 
ARTICLE
SiO 2 nanoshells were slightly better retained by the injected tumors, and for both types of nanoshells there was substantial activity in other organs. The activity in the liver and the spleen were expected as these organs are associated with filtration of particulates, and some are expected to escape due to the relatively large size of the injection volume (100 μL) compared to the size of the tumor (∼1000 mm 3 ). The radioactivity observed in the kidney was unexpected since it has been stated by Longmore et al. that larger particles (∼8 nm or larger) cannot readily be excreted by the kidneys due to the structure and pore size throughout the kidney. 36 However, as previously stated the biodistribution is sensitive to the nanoparticle size, composition, processing, and injection conditions. For example, Lu et al. using ∼100 nm mesoporous silica nanoparticles found that more than 90% could be excreted in the urine and feces over 96 h, 7 and Decuzzi et al. were able to detect 1000 nm solid silica nanoparticles in the kidneys by ICPÀAES; therefore, it is possible that some particles are present within the kidneys. 25 Alternatively, the radioactivity observed in the kidney may arise from shell fragments or surface degradation of the nanoshells and subsequent release and renal filtration of the 111 In-DTPA complex similar to the effect that was observed by Kommerredy et al. with degradable gelatin nanoparticles. 26 The effect on biodistribution of free versus bound 111 In-DTPA has been studied by Paik et al.
using antibodies. It was determined that when 111
In-DTPA was linked to antibodies with cleavable disulfide and diester linkages compared to noncleavable linkers, the cleaved 111 In-DTPA complexes had an accelerated clearance from circulation in rats. 37 Another example of rapid clearance of free 111 In-DTPA has been demonstrated in Wistar rats. Only 2 h after intravenous administration of 111 In-DTPA the largest retained dose was found in the kidneys, which only retained an average 0.126% injected dose/gram. 38 Li et al. found that when studying the biodistribution of 111 In-DTPA in mammary tumor bearing mice, the 111 In-DTPA was cleared rapidly from the blood with insignificant retention in the tumors. 39 Overall, 111 In-DTPA alone is not well retained in vivo and rapidly cleared through the renal system unless it is anchored by a macromolecule or particle that is not readily cleared. As a result, it is likely that the radioactive signal retained by the animals over the course of 72 h in the present work is predominantly due to indium retained by surface anchored DTPA on nanoshells. Furthermore, as seen in Figure 4E there was also a strong signal in the kidney from the nonbiodegradable pure SiO 2 nanoshells, which is more consistent with the kidneys retaining some of the nanoshells. Free 111 In 3þ released from the chelator is known to bind plasma transferrin and follow a similar biodistribution as iron bound transferrin. 40 Therefore, free 111 In 3þ would not be expected to remain largely confined to the injection site of nanoshells over the course of 72 h as it appears by scintigraphy. The distribution of pure SiO 2 nanoshells appear to have a similar profile to the distribution of FeÀSiO 2 nanoshells for intratumoral delivery, but much more signal is retained by these particles especially in the injected tumor and in the kidneys. Part of this difference can be attributed to normalization by organ mass; for this experiment the tumors for the FeÀSiO 2 nanoshell injection were on average over double the mass compared to pure SiO 2 nanoshells. Another difference which can be accounted for is that in one of the injections of FeÀSiO 2 nanoshells, a vessel was nicked almost immediately during the intratumoral injection, which partially delivered some particles systemically and shifted the average values and standard deviations, most noticeably in the case of the spleen. In well vascularized tumors, it is difficult to predict and avoid the vasculature when performing the intratumoral injections. For both particles, some signal was observed in the control tumors that received no direct injection.
Since a small fraction of nanoshells passively accumulate in the tumors during intratumoral delivery, the nanoshells were also administered intravenously in the same murine model to study their biodistribution and potential use in tumor detection using gamma imaging. Nanoshells were injected intravenously and planar γ-scintigraphic imaging was performed as shown in Figure 5AÀH . After 72 h, animals were sacrificed, the organs were harvested, and total organ radioactivity was measured with the use of a γ-counter. Figure 5A shows that the particles are initially spread throughout the entire body of the animal with an initial high accumulation in the liver. However, even immediately after initial injection of the FeÀSiO 2 nanoshells seen in Figure 5A , an outline of the tumors (two bilateral lobes on the legs near the bottom of the mouse at the center of the image) can be observed at the bottom of the mouse. The tumor images become increasingly distinct over time in Figure 5CÀD . It is hypothesized that the nanoparticles retained by the tumor are a product of the enhanced permeation and retention (EPR) effect which has been documented for various in vivo tumor models. 41À43 The poorly developed vasculature in the tumor sequesters and retains macromolecules and nanoparticles within the tumor due to poor circulation, drainage, and leakiness. The FeÀSiO 2 and the SiO 2 nanoshells had about the same amount of accumulation in the tumor as measured by scintigraphy. Furthermore, the amount of FeÀSiO 2 compared to the SiO 2 nanoshells retained by each tumor were approximately constant, when normalized by tumor mass, as evidenced by the nearly equal values of percent injected dose per gram tumor for both groups of particles ( Figure 5I ). With the exception of a larger signal strength in the liver, as seen in Figure 5EÀI , the pure SiO 2 nanoshells exhibited a similar biodistribution ARTICLE profile as the FeÀSiO 2 nanoshells. The enhanced liver signal for pure SiO 2 nanoshells compared to that of FeÀSiO 2 nanoshells was initially considered an aberration; however, verification by experimental repetition showed this to be consistent and not an artifact. Previous research has documented that extrahepatic tumors may significantly alter liver function. 44À48 It was found that even a tumor grown in the quadriceps of a mouse could have an impact on various hepatic receptors' expression and function, which can result in perturbed liver metabolism. 45 It is possible that the tumors grown could have affected the cell surface chemistry and retention of the nanoshells within the liver, which may account for the differences in particle retention observed. It was noted that the enhanced liver accumulation of pure SiO 2 nanoshells compared to FeÀSiO 2 nanoshells after IV injection was not observed in healthy mice ( Figure 6 ). Alternatively, it is possible that the overall lower liver signal that is found in the FeÀSiO 2 nanoshells is due to the effects of biodegradation, which is further accentuated by the higher metabolic activity of rapidly growing tumor tissue. It has been hypothesized that the FeÀSiO 2 nanoshells degrade via transferrin-mediated pathway, 30 and it is known that many cancers overexpress transferrin receptors, 49À51 which may accelerate FeÀSiO 2 nanoshell degradation.
For ultimate clinical applications of FeÀSiO 2 nanoshells as stationary ultrasound guide markers, it is critical to establish whether adverse effects could occur if the particles were inadvertently administered intravenously or intra-arterially. It is also important to define the destination of particles that might leak from the tumor. To examine these scenarios, four healthy nu/nu mice per group were injected intravenously through the tail vein with 100 μL of 111 In labeled gas filled 500 nm FeÀSiO 2 and SiO 2 nanoshells and imaged by gamma scintigraphy. Whole animal scintigraphy showed that the majority of the FeÀSiO 2 nanoshells localize to the liver ( Figure 6AÀD ). Organ γ-counting after sacrifice ( Figure 6E ), showed a substantial amount of signal in the kidneys and liver, but very little signal was detected elsewhere. The amount of signal in the kidneys shown in Figure 6E appears higher than in ARTICLE scintigraphy due to normalization against mass; however, quantification by γ-counting or scintigraphy showed the liver radioactivity was greater for both intratumoral and IV delivery. These results are consistent with the hypothesis that the intact 500 nm nanoparticles are taken up by the liver, but a small fraction of particles or released radiolabel and surface degraded products are retained by the renal system. The profiles of the distributions for both types of nanoshells (pure SiO 2 and FeÀSiO 2 ) are very similar; however, the remaining radioactivity for the biodegradable FeÀSiO 2 nanoshells remains consistently lower even in healthy animals. This is consistent with some surface degradation followed by release and clearance of the radiolabel since it was previously demonstrated in Figure 3 that some ultrasound signal is present after 10 days. Therefore, some nanoshells remain active in vivo within the Py8119 tumors 10 days after intratumoral delivery even though there may be partial surface degradation and loss of the surface anchored radiolabel.
CONCLUSIONS
This is the first report of the biodistribution for intratumoral injection of any biodegradable calcinated silica particle and the first report of a silica particle biodistribution determined using 111 In-DTPA labeling.
It has been shown that the perfluoropentane gas filled nanoshells can be intratumorally injected and imaged intermittently by color Doppler ultrasound over the course of 10 days. The increase in ultrasound imaging lifetime from previous reports is attributed to the thicker shell, which results from the integration of iron into the silica shell, and leads to a slower rate for gas escape. Intravenous delivery of radioactive FeÀSiO 2 -111 In-DTPA nanoshells and radioimaging shows rapid uptake by the liver, which is consistent with previous reports for injection of noncalcinated and calcinated silica particles. Some signal is observed in the kidneys, which has been observed previously for similar sized silica particles. Intratumoral injection results in most particles being retained by the tumor, and those that escape have a biodistribution similar to that The ultrasound imaging was performed with the Siemens Sequoia 512 (Mountainview, CA) with the Acuson 15L8 transducer that is commonly used for clinical US imaging. During imaging of the nanoshells, US parameters (frequency, focal depth, output power, filters and gains) were optimized in order to maximize signals from nanoshells while reducing background, which is a typical procedure in clinical contrast enhanced ultrasound (CEUS). Fluorescence imaging was performed by Ziess Axio Z1 fluorescence microscope. A CRC15 Dose Calibrator (Capintec, Inc., Ramsey, New Jersey) was used to measure doses as well as 111 In retention on DTPA functionalized particles. A high resolution gamma camera (γ1 Imager, BioSpace, Paris France) was used for planar scintigraphic imaging with a medium-energy high sensitivity collimator and dual energy windows set at 145À195 keV and 208À282 keV for detecting 111 In. Radioactivity of resected mouse organs was measured by an autowell gamma counter (Gamma 9000, Beckman Instruments, Fullerton CA).
Animals and Tumor Model. The 6-week-old female nu/nu mice were purchased from Charles River Laboratories and housed in a UCSD approved animal housing facility. Animals were fed Harlan Tecklad rodent feed and kept at 22°C with a 12 h light/ dark cycle. After an acclimation period of 10 days, 10 6 Py8119 breast cancer cells were injected subcutaneously and the resulting tumors were grown to 1000 mm 3 in volume. This cell line derived from the spontaneous polyomavirus middle T oncogene (PyVmT) mouse model of breast cancer represents the claudin low subtype of human breast cancer and has been previously used for surgical imaging studies. 52 Animals were scanned about two weeks after implantation, were anesthetized with isoflurane gas, and sacrificed by CO 2 asphyxiation post-experimentation.
Nanoshell Synthesis. Iron(III) ethoxide was first suspended in ethanol at a concentration of 20 mg/mL in an inert environment, and this solution was bath sonicated for 60 min. The iron ethoxide solution was mixed with pure TMOS at a ratio of 1:0.27 and was bath sonicated for an additional 10 min. This mixture was added to an Eppendorf tube with 500 nm amino-polystyrene templates in ethanol, which was subsequently pulse-vortexed at 3000 rpm for 5 h. After the reaction was complete, the particles were washed twice with ethanol by centrifugation to remove excess unreacted materials and left to dry overnight. Once dry, the particles were calcined at 550°C for 18 h. There are approximately 7 Â 10 9 nanoshells/mg after calcination. Nanoshells were stored dry until needed for gas filling or functionalization. Nanoshells were characterized by TEM and SEM as seen in Figure 1 . Pure SiO 2 nanoshells were synthesized as previously described. 8, 9, 53 Nanoshell size distributions were determined from SEM images by individually measuring the diameters of 300 particles from multiple images in various fields of view using Image J for the FeÀSiO 2 and pure SiO 2 nanoshells. Nanoshell Functionalization. FeÀSiO 2 nanoshells were suspended in ethanol at a concentration of 3 mg/mL in an Eppendorf tube. Separately, 1 μL of 3-APTES was added to 150 μL of ethanol in an Eppendorf tube, the solution was briefly mixed, and a 50 μL aliquot was removed and added to the nanoshell suspension. The nanoshells were pulse-vortexed at 3000 rpm for 24 h after which they were washed twice with ethanol and resuspended in DMSO. Then, 1 μL of 1 μg/mL of DTPA-isothiocyanate or 2 μL of 10 mg/mL of FITC was added to the nanoshells solution and pulse-vortexed for an additional 24 h. The nanoshells were washed twice with DMSO and once with ethanol. The nanoshells were dried and stored at 4°C until needed. For pure silica nanoshells, the same processes were used, but the starting concentration was halved to account for differences in particle masses and retain an equivalent particle count.
Indium-111 Labeling. DTPA functionalized nanoshells were filled with perfluoropentane (PFP) as described previously 9 and suspended in 2.0 M sodium citrate solution at a concentration of 4 mg/mL (FeÀSiO 2 ) or 2 mg/mL (pure SiO 2 ). A 2 mg portion of the FeÀSiO 2 nanoshells or 1 mg of the SiO 2 nanoshells was pipetted into an Eppendorf tube and incubated with ∼100 μC of indium-111 chloride for 30 min; 90% of the solution was removed from the Eppendorf tube and washed once with Milli-Q purified water and twice with ethanol. The nanoshells and the discarded supernatant were measured by dose calibrator in between each wash to track the indium retention on the nanoshells. After being washed, the nanoshells were dried under vacuum, filled with PFP gas, and suspended at a concentration of 4 mg/mL (FeÀSiO 2 ) or 2 mg/mL (SiO 2 ) in Milli-Q water.
Ex Vivo Doppler Ultrasound in Mastectomy Tissue. IRB approval was obtained to test in human tissue from mastectomy patients with palpable tumors. The mastectomy specimens were imaged ex vivo using ultrasound B-mode to identify the tumor. Nanoshells were injected peritumorally under ultrasound guidance, and confirmation of particle injection was visualized by color Doppler ultrasound. Subsequently, the mastectomy specimen ARTICLE was cut with the pathologist and a section of tumor and surrounding breast tissue was fixed in formalin. The needle used to inject the particles was left in place to guide the track of the particles. To better track and visualize the nanoshells under brightfield microscopy, the particles were suspended in a 10% (v/v) India ink solution. Additionally, nanoshells were covalently modified with fluorescein isothiocyanate (FITC) for fluorescent visualization.
Intratumoral Nanoshell Ultrasound Imaging Longevity. Eight Py8119 tumor bearing nu/nu mice were used to determine the in vivo ultrasound imaging longevity. For ultrasound imaging, each animal received a 50 μL injection of PFP-filled FeÀSiO 2 nanoshells directly into the tumor. The tumors were imaged intermittently with color Doppler ultrasound at an MI of 1.9 and a frequency of 7 MHz over the course of 14 days. The color Doppler signal width was measured from each imaging cycle and plotted over time.
Nanoshell Biodistribution in Py8119 Tumor Bearing nu/nu Mice. Four Py8119 tumor bearing nu/nu mice per group, each carrying two tumors on their posterior regions, were used to establish biodistribution when nanoshells were administered directly into a tumor or intravenously (four groups total). An amount of 100 μL of DTPA functionalized, 111 In labeled nanoshells was injected directly into a single tumor of each animal. Subsequent planar scintigraphic imaging was performed during the initial injection, 1 h postinjection, 24 h postinjection, and 72 h postinjection. Scintigraphic imaging time was preset to 15 min per imaging time point. The mice were sacrificed and the harvested organs were analyzed by gamma counter. For all scintigraphic images, the display range was fixed between 0 and 1.5.
Nanoshell Biodistribution in Healthy nu/nu Mice. Four healthy nu/nu mice per group were used to establish the biodistribution when nanoshells were administered intravenously to mimic the biodistribution of particles which might leak out of a small tumor after intratumoral (IT) injection. A 100 μL portion of DTPA functionalized, 111 In labeled nanoshells was injected via the tail vein. Subsequent planar scintigraphic imaging was performed during the initial injection, 1 h postinjection, 24 h postinjection, and 72 h postinjection. Scintigraphic imaging time was preset to 15 min per imaging time point. The mice were sacrificed, and the harvested organs were analyzed by gamma counter. For all scintigraphic images, the display range was fixed between 0 and 1.5.
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